NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Not that it much matters, but I don’t think that’s the case. I don’t think they’ve ever been waiting for that update. However, I do think they were close to a publication of their article, only to find there was a very detailed update from the FDA CDER oncology doctors in the Annals journal. So my thinking is that they felt it was more important to marginally address that so-called update to the guidance contained in that Annals article in the DCVax-L article. And that may have slowed down the process a bit by some weeks or month(s). All my opinion, sort of.